FEATURED SLIDESHOW
Who Is The Worst CEO?Mad Money needed new inductees for its
Wall of Shame, so we asked viewers for
nominations.
RECENT POSTS
- Money-Making Mood Stabilizers
- No Product Revenues, Plenty of Risk: Buy Exelixis?
- Lightning Round: Caterpillar, Starbucks, Intel and More
- Lightning Round OT: SanDisk, Marvel Entertainment and More
- The Discounter’s Dilemma
- Cramer: Earnings, IPOs Dominate Next Week’s Game Plan
- Cramer: GE Upgrade 'Very Powerful'
- 2 Takeover Targets in the Pharma Market
- Lightning Round: Bank of America, Crocs, Inergy and More
- Lightning Round OT: Royal Bank of Scotland, Seabridge Gold and More

MAD MONEY FEATURES
Watch the Lightning Round whenever and wherever you want.
Grab this all-in-one application and get recaps of the show sent right to your desktop or blog.
Admit it: You’ve always wanted to hit the “They know nothing!” button. Here’s your chance.
Check out the Mad Money host on set, back to school, behind the scenes and more.
Get all your favorite Cramer clips right here.
Buy Cramer books, bobbleheads and other Mad Money merchandise.
Pick up the phone! It’s Cramer! New Mad Money sounds for your cell phone.
Mad Money’s mobile. Get show highlights sent to your phone.
Cramer says: “There’ll be many failed banks coming up – many, many. What’s going to happen – and we’re going to have [FDIC Chairwoman] Sheila Bair on the show tomorrow – you’re going to see banks that are well capitalized, like First Niagara, being able to buy other banks that get in trouble. That’s why I like FNFG. It reminds me very much of some of the banks, like Fleet, that I invested in, in the late ‘80s.”
___
Jim: I started purchasing Pfizer [PFE
Loading...
()
] early this year because of the acquisition of Wyeth [WYE
Loading...
()
]. With the acquisition it was said that PFE would be able to see some great profits and returns from the deal. Now with health care and pharma being on Obama's hit list, how could this impact PFE's stock and will it? Thank you for your time and a great big Army Booyah! --Jerome
Cramer says: “Thank you for serving…Pfizer I just don’t think has anything going for it. I don’t think the merger’s going to matter. I think it’s a deadweight stock, and I don’t want you buying Pfizer.”
Watch the video for Cramer’s calls on CardioNet [BEAT
Loading...
()
] and Cougar Biotechnology [CGRB
Loading...
()
].
Call Cramer: 1-800-743-CBNC
Questions for Cramer?
Questions, comments, suggestions for the Mad Money website?



